Group I Intron as a Potential Target for Antifungal Compounds: Development of a Trans-Splicing High-Throughput Screening Strategy

Molecules. 2023 May 31;28(11):4460. doi: 10.3390/molecules28114460.

Abstract

The search for safe and efficient new antifungal compounds for agriculture has led to more efforts in finding new modes of action. This involves the discovery of new molecular targets, including coding and non-coding RNA. Rarely found in plants and animals but present in fungi, group I introns are of interest as their complex tertiary structure may allow selective targeting using small molecules. In this work, we demonstrate that group I introns present in phytopathogenic fungi have a self-splicing activity in vitro that can be adapted in a high-throughput screening to find new antifungal compounds. Ten candidate introns from different filamentous fungi were tested and one group ID intron found in F. oxysporum showed high self-splicing efficiency in vitro. We designed the Fusarium intron to act as a trans-acting ribozyme and used a fluorescence-based reporter system to monitor its real time splicing activity. Together, these results are opening the way to study the druggability of such introns in crop pathogen and potentially discover small molecules selectively targeting group I introns in future high-throughput screenings.

Keywords: Fusarium; HTS; RNA; group I; ribozyme; self-splicing.

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology
  • High-Throughput Screening Assays*
  • Introns / genetics
  • RNA Splicing
  • RNA, Catalytic* / chemistry
  • Trans-Splicing

Substances

  • Antifungal Agents
  • RNA, Catalytic